Ernesto Ang

Implications of the CVOTs in Type 2 Diabetes

New AACE ABCD Algorithm: Redefining Obesity Assessment and Care

Insulin Treatment in Elderly

Diabetes Management during Ramadan

Decoding Diabetes Endotypes A Pathway to Precision Care

Hypercortisolism in the pathogenesis of Diabetes Explained:The Noxious Nine

Spontaneous hypoglycemia: Part 6 of Hypoglycemia Series

Management and prevention of hypoglycemia:Part 5 of Hypoglycemia series

Prevalence & Clinical Impact of Hypoglycemia:Part 4 of Hypoglycemia Series:

Hypoglycemia Series : Part 3 hypoglycemia unawareness (slight modifications)

Hypoglycemia Series Part 3 Hypoglycemia Unawareness

Hypoglycemia Part 2 Symptoms and Recognition

Hypoglycemia series Part 1 What is hypoglycemia

Part 6: Insulin Transition across care settings - Inpatient Hyperglycemia: From Crisis to Control

Part 5: Insulin Therapy in Hyperglycemic Crises (DKA and HHS )

Part 4 Insulin Therapy in Critically Ill Patients- Inpatient Hyperglycemia:From Crisis to Control

Part 3 Insulin therapy in non-critically ill Inpatient

Part 2: Inpatient Glycemic Target – Inpatient Hyperglycemia: From Crisis to Control

Part I: Defining Inpatient Hyperglycemia:From Crisis Toward Control

Part 6 Fruit is forbidden? Glycemic index vs glycemic load explained

Part 5 Thin people don’t get diabetes: Busting the BMI myth

Pills vs Insulin: Which Is Safer? | Diabetes Myths (Part 4)

Is Insulin Dangerous? | Diabetes Myths Busted (Part 3)

Can Diabetes Be Reversed? | Myth-Busting Series (Part 2)

Does Sugar Cause Diabetes? | Demystifying Diabetes: Myth-Busting Series (Part 1)

Unveiling Diabetic Autonomic Neuropathy The Silent Diabetes Threat

Part 4 Conversion of Glucose to ATP

Part 3 Glucose Transporters and Enzymatic Activity

Physiology of Carbodydate and related metabolism part 2 transport across cell membrane

Physiology of Carbohydrate and Related Metabolism part 1